Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2023.11.21
ag真人平台官方：关于变更H股募集资金使用用途的公告
2023.11.21
ag真人平台官方：关于修订公司治理相关制度的公告
2023.11.21
ag真人平台官方：关于召开2023年第一次临时股东大会、2023年第一次A股类别股东会议及第一次H股类...
2023.10.30
ag真人平台官方：2023年三季度报告
2023.08.30
ag真人平台官方：2023年半年度报告
2023.08.30
ag真人平台官方：2023年半年度报告摘要
2023.08.30
ag真人平台官方：独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和...
2023.08.30
ag真人平台官方：关于控股股东承诺不减持公司股份的公告
2023.08.21
ag真人平台官方：独立董事关于第六届董事会第二次会议相关事项的独立意见
2023.08.21
ag真人平台官方：关于变更财务总监的公告
第一页
上一页
4
5
6
7
8
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
